Chris Nolet - Director at Revance Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RVNC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Chris Nolet since 7/7/2023

Holdings reported by Chris Nolet for Revance Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 43,606 $166 K $3.80 May 1, 2024 Direct
Stock Option (Right to buy) 23,458 May 1, 2024 Direct Common Stock

Transactions reported by Chris Nolet for Revance Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership